Table 2 Duration of illness, clinical symptoms, and laboratory data in relation to depression
From: Impact of depression on quality of life in systemic lupus erythematosus patients
Variables | Total (N = 32) | Depressive group (N = 15) | Non-depressive group (N = 17) | P value |
|---|---|---|---|---|
Duration of illness in years (mean ± SD) | 6.34 ± 4.5 | 6.46 ± 5.54 | 6.23 ± 3.52 | 0.888 |
Clinical symptoms N (%) | ||||
Myalgia number N (%) | 26 (81%) | 13 (87.7%) | 13 (76.5%) | 0.392 |
Lupus headache N (%) | 25 (78%) | 13 (86.7%) | 12 (70.6%) | 0.254 |
Arthritis N (%) | 22 (69%) | 13 (86.7%) | 9 (52.9%) | 0.046 |
Alopecia N (%) | 22 (69%) | 10 (66.7%) | 12 (70.6%) | 0.555 |
Oral/nasal ulcers N (%) | 22 (69%) | 12 (80%) | 11 (64.7%) | 0.287 |
Malar rash N (%) | 20 (63%) | 10 (66.7%) | 10 (58.8%) | 0.464 |
Fever N (%) | 24 (51%) | 13 (86.7%) | 11 (64.7%) | 0.152 |
Vasculitis lesion N (%) | 4 (13%) | 2 (13.3%) | 2 (11.8%) | 0.650 |
Retinal disease N (%) | 3 (9%) | 2 (13.3%) | 1 (5.9%) | 0.452 |
Cerebrovascular stroke N (%) | 3 (9%) | 1 (6.7%) | 2 (11.8%) | 0.548 |
Laboratory data (mean ± SD) | ||||
Protein 24 h in urine (mean ± SD) | 264.84 ± 227.7 | 231.7 ± 236.7 | 294.1 ± 222. | 0.448 |
Blood platelets (mean ± SD) | 259.9 ± 64.95 | 262.3 ± 70.4 | 257.9 ± 61.9 | 0.854 |
Blood WBCs (mean ± SD) | 5.78 ± 2 | 5.9 ± 1.7 | 5.7 ± 2.4 | 0.830 |
Blood sugar (normal range 70–100 mg/dl (mean ± SD) | 88.31 ± 14.22 | 92 ± 15.5 | 85.1 ± 12.6 | 0.172 |
SLEDAI-2K (mean ± SD) | 19.34 ± 7.46 | 21.6 ± 5.36 | 17.32 ± 8.58 | 0.109 |